Aldagen Files for IPO

Aldagen Inc., a Durham, N.C.-based developer of clinical-stage regenerative therapies, has filed for an $80.5 million IPO. It plans to trade on the Nasdaq under ticker symbol ALDH, with Wachovia Securities and Cowen & Co. serving as co-lead underwriters.

The company has raised around $65 million in VC funding since 2000, from firms like Intersouth Partners (41.6% pre-IPO stake), Harbert Venture Partners (14.7%), The Aurora Funds (12.3%), Tullis-Dickerson (9.3%) and Trelys Funds (5.4%). www.aldegen.com